Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
HRQOL en cognitieve functie na lomustine-temozolomide versus temozolomide
dec 2019 | Neuro-oncologie